1. Home
  2. HBIO vs ITOC Comparison

HBIO vs ITOC Comparison

Compare HBIO & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$9.50

Market Cap

26.5M

Sector

Industrials

ML Signal

N/A

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$1.96

Market Cap

28.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HBIO
ITOC
Founded
1901
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
28.1M
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
HBIO
ITOC
Price
$9.50
$1.96
Analyst Decision
Hold
Analyst Count
2
0
Target Price
★ $11.50
N/A
AVG Volume (30 Days)
★ 26.4K
24.3K
Earning Date
11-10-2026
03-19-2027
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $116,176,000.00
N/A
Revenue This Year
$4.09
N/A
Revenue Next Year
$5.22
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.40
$0.22
52 Week High
$10.20
$4.49

Technical Indicators

Market Signals
Indicator
HBIO
ITOC
Relative Strength Index (RSI) 66.51 47.23
Support Level $8.01 $0.27
Resistance Level N/A $4.49
Average True Range (ATR) 0.51 0.45
MACD 0.09 -0.13
Stochastic Oscillator 66.51 29.37

Price Performance

Historical Comparison
HBIO
ITOC

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

Share on Social Networks: